新型三价灭活沙门菌疫苗在鸡群中的安全性与效力
本研究在商品化饲养条件下评估含肠炎、鼠伤寒和婴儿沙门菌血清型的新型三价灭活疫苗。10,229只肉种母雏在10和17周龄经胸肌注射接种,疫苗安全且未检出局部或全身反应。接种诱导的血清理特异性抗体至少维持至56周龄,同源攻击后粪便排菌和器官侵袭显著减少,异源攻击后粪便排菌也显著减少。
要点
- 新型三价灭活沙门菌疫苗在商品化鸡群中安全,未检出相关局部或全身反应。
- 接种后血清理特异性抗体至少维持至56周龄。
- 同源攻击减少粪便排菌和器官侵袭,异源攻击减少粪便排菌。
核心结论
- 该新型三价灭活沙门菌疫苗安全,并能诱导持续至至少56周龄的血清抗体,在同源和异源攻击下减少粪便排菌。
研究设计与样本
- 在商品化饲养条件下对10,229只肉种母雏在10和17周龄经胸肌肌内注射接种新型三价灭活沙门菌疫苗。
主要发现
- 疫苗安全,未检出与疫苗相关的局部或全身反应或对鸡生产性能的不良影响。
- 接种导致血清理特异性抗体显著升高,并至少维持至56周龄。
- 接种鸡在同源攻击后粪便排菌和器官侵袭显著减少。
- 接种鸡在异源攻击(S. Hadar,O:8,血清群C2)后粪便排菌显著减少。
关键数值与推荐
- 疫苗含肠炎沙门菌(O:9,血清群D)、鼠伤寒沙门菌(O:4,血清群B)和婴儿沙门菌(O:7,血清群C1),佐剂为氢氧化铝凝胶。
- 接种程序为10和17周龄经胸肌肌内注射。
临床怎么用
- 该疫苗可作为综合沙门菌控制规划的一部分,用于减少人类食源性感染和家禽生产中的抗生素使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Food poisoning in humans caused by Salmonella enterica remains a significant global public health concern, with the majority of infections associated with the consumption of contaminated eggs or poultry products. The safety and efficacy of a novel inactivated trivalent Salmonella enterica vaccine containing in addition to Salmonella serovars Enteritidis (O:9, serogroup D) and Typhimurium (O:4, serogroup B) also serovar Infantis (O:7, serogroup C1) formulated with an aluminium hydroxide-gel adjuvant was evaluated under field conditions. A total of 10,229 broiler breeder pullets, housed under commercial conditions, were vaccinated at 10 and 17 weeks of age by the intramuscular route in the breast muscle. The vaccine was safe with no local or systemic reactions or adverse effects on bird performance related to the vaccine detected. Vaccination resulted in notable increases in serovar specific antibodies that were maintained until at least 56 weeks of age. Vaccinated birds subjected to homologous challenges around onset of lay showed significantly reduced faecal shedding and organ invasion. Following heterologous challenge with S. Hadar (O:8, serogroup C2) faecal shedding was significantly reduced. These results demonstrate that this novel vaccine could play a significant role in a comprehensive Salmonella control programme intended to reduce both the incidence of food poisoning in humans and the use of antibiotics during poultry production.
引用
- Crouch CF, Nell T, Reijnders M, et al. Safety and efficacy of a novel inactivated trivalent Salmonella enterica vaccine in chickens. Vaccine. 2020. PMID: 32888739. doi:10.1016/j.vaccine.2020.08.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。